💨 Abstract
In Q1 2025, Houston-based Plus Therapeutics Inc. (PSTV) reported a net loss of $17.4 million, equivalent to $1.19 per share. Adjusted losses were 56 cents per share. The company, specializing in cell therapies, generated $1.1 million in revenue during the period.
Courtesy: WTOP Staff
Suggested
Takeaways from AP’s report on how federal public health cuts are affecting communities across the US -
Pope Leo XIV updates his Peruvian citizen registration with his new Vatican address -
Disminución de turistas activa alarmas en Costa Rica -
Surt, economista: “El gobierno enfrenta un triple desafío: equilibrio fiscal, social y externo” -
BGE and Delmarva Power rates to increase by $16 but will be spread out -
Gap: Fiscal Q1 Earnings Snapshot -
Lawyer says Trump administration revokes parole of Mexican girl receiving lifesaving care in US -
Ituran: Q1 Earnings Snapshot -